Elderly mice suffering from age-related heart disease saw a significant improvement in cardiac function after being treated with the FDA-approved drug rapamycin for just three months.
The research, led by a team of scientists at the Buck Institute for Research on Aging, shows how rapamycin impacts mammalian tissues, providing functional insights and possible benefits for a drug that has been shown to extend the lifespan of mice as much as 14 percent. There are implications for human health in the research appearing online in Aging Cell: heart disease is the leading cause of death in the U.S., claiming nearly 600,000 lives per year.
Rapamycin is an immunosuppressant drug which can be used to help prevent organ rejection after transplantation. It is also included in treatment regimens for some cancers. In this study, rapamycin was added to the diets of mice that were 24 months old – the human equivalent of 70 to 75 years of age. Similar to humans, the aged mice exhibited enlarged hearts, a general thickening of the heart wall and a reduced efficiency in the hearts ability to pump blood.
The mice were examined with ultrasound echocardiography before and after the three-month treatment period – using metrics closely paralleling those used in humans. Buck Institute faculty Simon Melov, PhD, the senior author of the study, said age-related cardiac dysfunction was either slowed or reversed in the treated mice. “When we measured the efficiency of how the heart pumps blood, the treated mice showed a remarkable improvement from where they started. In contrast, the untreated mice saw a general decline in pumping efficiency at the end of the same three month period,” he said. “This study provides the first evidence that age-related heart dysfunction can be improved even in late life via appropriate drug treatment,” added Melov, who said the treated mice saw a reduction in heart size, reduced stress signaling in heart tissues and a reduction in inflammation.
Buck researchers, utilizing genome analysis tools, uncovered suites of related genes which rapamycin modulates in the heart. “Rapamycin affected the expression of genes involved in calcium regulation, mitochondrial metabolism, hypertrophy and inflammation,” said Melov. “We also carried out behavioral assessments which showed the treated mice spent more time on running wheels than the mice who aged without intervention.”
“Little has been known about the functional ramifications of rapamycin in mammalian tissues,” said Buck Institute President and CEO Brian Kennedy, PhD, a co-author of the paper. “These findings are significant because we have no interest in simply extending lifespan without an accompanying improvement in the health and quality of life.” He added, “It is particularly encouraging that, in this case, an already-approved drug that extends lifespan also improved function late in life.”
The Latest Bing News on:
Age-Related Heart Disease
- Research points to new hope for treatment-resistant age-related macular degenerationon March 1, 2021 at 4:51 am
An oxysterol that accumulates in the eye with age can transform choroidal endothelial cells; interfering with the process might help patients with treatment-resistant age-related macular degeneration.
- Vitamin E is a powerful antioxidant that can boost your immune system - here's how to get enough of iton February 28, 2021 at 9:15 pm
Vitamin E is especially great for boosting your immune system and is also important for the health of your heart, brain, eyes, and skin.
- Alzheimer’s and Women: How to Protect Yourselfon February 27, 2021 at 10:39 am
Women suffer from Alzheimer's at a far higher rate than men. Still, it's possible to take action to help decrease your odds of getting it.
- Weak Heart Makes Your Brain Sufferon February 27, 2021 at 1:28 am
People with heart problems experience noticeable cognitive deficits. Possible reasons could be impaired blood supply to the brain and dysfunction of the hippocampus, which is the memory's control ...
- Atherosclerosis can speed up the development of clonal hematopoiesison February 26, 2021 at 11:22 pm
Billions of peripheral white blood cells are produced every day by the regular divisions of hematopoietic stem cells and their descendants in the bone marrow.
- Study: Heart problems cause disturbed gene activity in the brain's memory centeron February 26, 2021 at 11:10 pm
Heart problems cause disturbed gene activity in the brain's memory center, from which cognitive deficits arise.
- A weak heart makes for a suffering brainon February 26, 2021 at 2:17 pm
Heart problems cause disturbed gene activity in the brain's memory center, from which cognitive deficits arise. Researchers at the German Center for Neurodegenerative Diseases (DZNE), the University ...
- A weak heart makes a suffering brainon February 26, 2021 at 12:08 pm
Heart problems cause disturbed gene activity in the brain's memory center, from which cognitive deficits arise. Researchers at the DZNE come to this conclusion based on laboratory studies. They ...
- World-First Fabry Disease Treated With Gene Therapyon February 25, 2021 at 11:58 am
A buildup of that can lead to problems in the kidneys, heart and brain ... for a rare childhood metabolic disorder known as Fabry disease. Gene Therapy Can Possibly Reverse Age-Related Pulmonary ...
- Regular health tests can prolong your lifeon February 22, 2021 at 2:17 pm
Not only does she get an annual wellness exam, but she also regularly gets other health screenings, including a bone density scan, a colonoscopy and an eye exam. Such recommended screenings look for ...
The Latest Google Headlines on:
Age-Related Heart Disease
The Latest Bing News on:
- AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivoon February 26, 2021 at 5:51 am
Axonal damage is an early step in traumatic and neurodegenerative disorders of the central nervous system (CNS). Damaged axons are not able to regenerate sufficiently in the adult mammalian CNS, ...
- Rimklb mutation causes male infertility in miceon February 25, 2021 at 7:38 am
Rimklb is a mammalian homologue of the E. coli enzyme RimK, which catalyzes addition of glutamic acid to the ribosomal protein S6. To date, no previous studies have shown any physiological role for ...
- Mammalian Target of Rapamycin: Biological Function and Target for Novel Anticancer Agentson February 23, 2021 at 4:00 pm
2010;67(24):2095-2106. The second mTOR complex, mTORC2, contains mTOR, mLST8, and several unique proteins, including rictor (rapamycin-insensitive companion of mTOR). Rapamycin and its analogues ...
- Rapamycin Treatment for a Child With Germline PTEN Mutationon February 18, 2021 at 4:00 pm
Diagnosis: PTEN hamartoma tumor syndrome, specifically Proteus syndrome. Management: Oral rapamycin. A 9-month-old boy with Proteus syndrome was referred to a specialist center for the management ...
- Everolimus for Advanced Pancreatic Neuroendocrine Tumorson February 17, 2021 at 4:00 pm
Everolimus, an oral inhibitor of mammalian target of rapamycin (mTOR), has shown antitumor activity in patients with advanced pancreatic neuroendocrine tumors, in two phase 2 studies. We evaluated ...
- Deep Longevity Publishes Article About Preventing COVID-19 and Agingon February 16, 2021 at 1:20 am
Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK: 0575.HK)'s Deep ...
- mTOR Inhibitors Synergize on Regression, Reversal of Gene Expression, and Autophagy in Hepatocellular Carcinomaon February 7, 2021 at 4:00 pm
Because mammalian target of rapamycin (mTOR) signaling is up-regulated in 50% of HCCs, we compared the effects of the U.S. Food and Drug Administration–approved mTOR-allosteric inhibitor, RAD001, with ...
- Researchers call for trials of rapamycin to treat COVID-19on February 3, 2021 at 4:00 pm
Researchers in the United States, China, and the UK have called for immediate large-scale clinical trials of an antibiotic called rapamycin as a prophylactic and treatment approach to coronavirus ...
- Targeted pathological collagen delivery of sustained-release rapamycin to prevent heterotopic ossificationon February 2, 2021 at 4:00 pm
The results presented here indicate that tendon stem/progenitor cells do not undergo osteochondrogenic differentiation when mTOR signaling is inactivated by gene knockout or rapamycin (RAPA) treatment ...
- Adiponectin receptor 1 variants contribute to hypertrophic cardiomyopathy that can be reversed by rapamycinon February 2, 2021 at 4:00 pm
Biochemical studies showed that ADIPOR1 variants dysregulate glucose and lipid metabolism and cause cardiac hypertrophy through the p38/mammalian target of rapamycin and/or extracellular ...